Research across borders

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find studies Explore world registries Peptide directory

Find a study

Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.

Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-09 10:11 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 1CompletedINTERVENTIONAL

Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans

ClinicalTrials.gov · NCT00393445 · Registry updated: 2011-10-04

Condition / research focus: Hyperglycemia
Sponsor: Ludwig-Maximilians - University of Munich
Countries with listed sites: Germany
Registry dates and results: Start: 2006-11. Completion: 2007-05 (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GLP-1 control (drug) — also listed as: GLP-1(7-36)amide
GLP-1 and Exendin(9-39) 300 (drug)
saline control (drug)
GLP-1 and Exendin(9-39) 600 (drug)
GLP-1 and Exendin(9-39) 900 (drug)
GLP-1 and Exendin(9-39) 1200 (drug)

Where the study takes place — 1 listed sites

Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.

Ludwig Maximilians University, Clinical Research Unit
Munich, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Comparison Between Patients With or Without Diabetes Recovery After Bariatric Surgery

ClinicalTrials.gov · NCT00834938 · Registry updated: 2011-08-11

Condition / research focus: Diabetes; Bariatric Surgery; Obesity
Sponsor: University of Campinas, Brazil
Countries with listed sites: Brazil
Registry dates and results: Start: 2007-07. Completion: 2010-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

No intervention (other)

Where the study takes place — 1 listed sites

LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP)
Campinas, São Paulo, Brazil
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Peanuts Second Meal Glycemic Response

ClinicalTrials.gov · NCT01413126 · Registry updated: 2011-08-10

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: Federal University of Vicosa
Countries with listed sites: Brazil
Registry dates and results: Start: 2009-10. Completion: 2011-02 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Whole peanuts without skins, Peanut butter, or no peanuts (control) (dietary_supplement)

Where the study takes place — 1 listed sites

Federal University of Viçosa
Viçosa, Minas Gerais, Brazil
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Glucose Metabolism in the Immediate and Short Term Follow up After Bariatric Surgery

ClinicalTrials.gov · NCT00488423 · Registry updated: 2011-06-22

Condition / research focus: Diabetes; Gastric Bypass
Sponsor: The Cleveland Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2006-11. Completion: 2008-11 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Mixed Meal Tolerance test, Hyperglycemic clamp (procedure) — also listed as: MMTT

Where the study takes place — 1 listed sites

Cleveland Clinic
Cleveland, Ohio, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Insulinotropic Effect of GIP and GLP-1 Before and After Reduced Glucose Tolerance

ClinicalTrials.gov · NCT01173978 · Registry updated: 2011-06-21

Condition / research focus: Insulin Resistance; Deteriorated Glucose Homeostasis; Inactivity
Sponsor: Glostrup University Hospital, Copenhagen
Countries with listed sites: Denmark
Registry dates and results: Start: 2010-04. Completion: 2010-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Steroid hormone (behavioral) — also listed as: Prednisolone
No intervention (other)

Where the study takes place — 1 listed sites

Department of Clinical Physiology
Glostrup Municipality, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus

ClinicalTrials.gov · NCT01342042 · Registry updated: 2011-04-26

Condition / research focus: Type 2 Diabetes
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Countries with listed sites: China
Registry dates and results: Start: 2011-03. Completion: 2011-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

rExenatide-4 (biological)

Where the study takes place — 1 listed sites

Peking University First Hospital
Beijing, Beijing Municipality, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to Dysinsulinism

ClinicalTrials.gov · NCT00847080 · Registry updated: 2011-04-26

Condition / research focus: Reactive Hypoglycemia
Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Countries with listed sites: Mexico
Registry dates and results: Start: 2008-12. Completion: 2011-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Sitagliptin phosphate (drug) — also listed as: Januvia
Placebo (drug)

Where the study takes place — 1 listed sites

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Mexico City, Mexico City, Mexico
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Gut Hormones After Roux-en-Y Gastric Bypass (RYGBP) Plus Gastric Fundus Resection

ClinicalTrials.gov · NCT01341028 · Registry updated: 2011-04-25

Condition / research focus: Morbid Obesity
Sponsor: University of Patras
Countries with listed sites: Greece
Registry dates and results: Start: 2007-05. Completion: 2010-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Roux-en-Y gastric bypass (LRYGBP) (procedure) — also listed as: LRYGBP
LRYGBP+gastric fundus resection (procedure)

Where the study takes place — 1 listed sites

University Hospital of Patras
Rio, Achaia, Greece
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET

ClinicalTrials.gov · NCT01185119 · Registry updated: 2011-03-22

Condition / research focus: Healthy
Sponsor: University of Aarhus
Countries with listed sites: Denmark
Registry dates and results: Start: 2010-06. Completion: 2011-03 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

native glp-1 (7-36) (drug) — also listed as: glucagon like peptide-1 (7-36)

Where the study takes place — 1 listed sites

Aarhus University, Institute of Pharmacology
Aarhus C, Aarhus, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus

ClinicalTrials.gov · NCT01208012 · Registry updated: 2011-03-15

Condition / research focus: Diabetes Mellitus, Type 2
Sponsor: ikfe-CRO GmbH
Countries with listed sites: Germany
Registry dates and results: Start: 2010-04. Completion: 2010-11 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Victoza® (drug) — also listed as: Victoza®, Liraglutide

Where the study takes place — 1 listed sites

IKFE Institute for Clinical Research and Development
Mainz, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Sweet Taste Receptors and the Secretion of Glucagon-like Peptide-1 and Peptide YY

ClinicalTrials.gov · NCT01088841 · Registry updated: 2011-02-23

Condition / research focus: Appetite and General Nutritional Disorders; Hormone Replacement
Sponsor: University Hospital, Basel, Switzerland
Countries with listed sites: Switzerland
Registry dates and results: Start: 2009-04. Completion: 2010-03 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

lactisole (dietary_supplement) — also listed as: Glucose, water

Where the study takes place — 1 listed sites

University Hospital Basel, Clinical Research Center
Basel, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Characterization of the Incretinpathy in Type 2 Diabetes Initiated After Sixty Years Old

ClinicalTrials.gov · NCT00843232 · Registry updated: 2011-02-04

Condition / research focus: Diabetes Mellitus, Type 2; Insulin Resistance
Sponsor: University of Campinas, Brazil
Countries with listed sites: Brazil
Registry dates and results: Start: 2009-07. Completion: 2010-09 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP)
Campinas, São Paulo, Brazil
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effect of GLP-1 and GIP on Insulin Secretion in Type-1 Diabetes Mellitus

ClinicalTrials.gov · NCT00603031 · Registry updated: 2011-01-21

Condition / research focus: Type-1 Diabetes Mellitus
Sponsor: Hvidovre University Hospital
Countries with listed sites: Denmark
Registry dates and results: Start: 2008-01. Completion: 2008-06 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

glucagon like peptide -1 (other)
NaCl (other)
glucose dependent insulinotropic polypeptide (other)

Where the study takes place — 1 listed sites

Dept. of Endocrinology, Hvidovre Hospital
Copenhagen, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes

ClinicalTrials.gov · NCT00993720 · Registry updated: 2011-01-21

Condition / research focus: Diabetes Mellitus
Sponsor: Hvidovre University Hospital
Countries with listed sites: Denmark
Registry dates and results: Start: 2009-10. Completion: 2010-10 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Liraglutide (drug)
Liraglutide (drug)
continuous insulin therapy (other)

Where the study takes place — 1 listed sites

Hvidovre University Hospital
Hvidovre, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Study of Postprandial Incretin Response in Women With Gestational Diabetes

ClinicalTrials.gov · NCT01274052 · Registry updated: 2011-01-11

Condition / research focus: Gestational Diabetes Mellitus
Sponsor: University Hospital, Gentofte, Copenhagen
Countries with listed sites: Denmark
Registry dates and results: Start: 2007-03. Completion: 2008-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Meal test (other)

Where the study takes place — 1 listed sites

Department of Internal Medicine, Glostrup Hospital
Glostrup Municipality, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Effect of Additional Treatment With EXenatide in Patients With an Acute Myocardial Infarction (the EXAMI Trial)

ClinicalTrials.gov · NCT01254123 · Registry updated: 2010-12-06

Condition / research focus: Patients With a First Acute Myocardial Infarction to be Treated With Primary Percutaneous Coronary Intervention (PCI).
Sponsor: Amsterdam UMC, location VUmc
Countries with listed sites: Netherlands
Registry dates and results: Start: 2009-11. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Exenatide infusion (drug)
Placebo infusion. (drug)

Where the study takes place — 1 listed sites

VU Medical Center
Amsterdam, Netherlands
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Exploratory Study of Additional Use of Scopolamine Butylbromide, Glucagon or NPO-11 Following Single Dose of NPO-11 in Healthy Adult Men

ClinicalTrials.gov · NCT00740324 · Registry updated: 2010-11-09

Condition / research focus: Healthy
Sponsor: Nihon Pharmaceutical Co., Ltd
Countries with listed sites: Japan
Registry dates and results: Start: 2008-08. Completion: 2009-07 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

NPO-11 (drug)
NPO-11 (drug)
NPO-11 (drug)

Where the study takes place — 1 listed sites

Facility not reported
Tokyo, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1 / Phase 2TerminatedINTERVENTIONAL

Treatment of Type 2 Diabetes Mellitus by Duodenal Exclusion Associated With Omentectomy: Clinical and Hormonal Study

ClinicalTrials.gov · NCT00566215 · Registry updated: 2010-07-23

Condition / research focus: Diabetes Mellitus, Type 2; Insulin Resistance; Obesity
Sponsor: University of Campinas, Brazil
Countries with listed sites: Brazil
Registry dates and results: Start: 2007-07. Completion: 2009-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Duodenal exclusion plus omentectomy (procedure) — also listed as: Duodenojejunal exclusion plus omentectomy, Duodenal-jejunal bypass plus omentectomy
Duodenal exclusion without omentectomy (procedure) — also listed as: Duodenojejunal exclusion, Duodenal-jejunal bypass

Where the study takes place — 1 listed sites

LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP)
Campinas, São Paulo, Brazil
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1 / Phase 2CompletedINTERVENTIONAL

Surgical Treatment of Non-obese Type 2 Diabetic Patients With Duodenal Exclusion

ClinicalTrials.gov · NCT00566358 · Registry updated: 2010-07-21

Condition / research focus: Diabetes Mellitus, Type 2
Sponsor: University of Campinas, Brazil
Countries with listed sites: Brazil
Registry dates and results: Start: 2006-01. Completion: 2009-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Duodenal exclusion surgery (procedure) — also listed as: Duodeno-jejunal exclusion, Duodenal-jejunal bypass

Where the study takes place — 1 listed sites

LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP)
Campinas, São Paulo, Brazil
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

GIP and GLP-1 on Gastric Emptying, Appetite and Insulin-glucose

ClinicalTrials.gov · NCT01079624 · Registry updated: 2010-03-03

Condition / research focus: Physiology; Gastroenterology; Endocrinology
Sponsor: Uppsala University
Countries with listed sites: Sweden
Registry dates and results: Start: 2006-08. Completion: 2009-11 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Glucose-insulinotropic peptide, Glucagon-like peptide-1 (other) — also listed as: GIP, GLP-1, Saline

Where the study takes place — 1 listed sites

Karolinska University Hospital
Stockholm, Stockholm County, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Explore the world’s study registries

These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.

Worldwide

Africa

Pan African Clinical Trial Registry ↗

Americas

Asia

Middle East

Europe

Oceania

Australia / New Zealand — ANZCTR ↗

Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.

Worldwide Study Finder

Loading registry information…

Worldwide Study Finder

Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.

Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.

Find a study

Registry search results

Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-09 10:11 UTC. Counts are registry matches, not unique peptides or a worldwide total.

Phase 1CompletedINTERVENTIONAL

Exendin(9-39)Amide as a Glucagon-like Peptide-1 (GLP-1) Receptor Antagonist in Humans

ClinicalTrials.gov · NCT00393445 · Registry updated: 2011-10-04

Condition / research focus: Hyperglycemia
Sponsor: Ludwig-Maximilians - University of Munich
Countries with listed sites: Germany
Registry dates and results: Start: 2006-11. Completion: 2007-05 (may be estimated). No results posted in this registry response.

Products and interventions (6)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

GLP-1 control (drug) — also listed as: GLP-1(7-36)amide
GLP-1 and Exendin(9-39) 300 (drug)
saline control (drug)
GLP-1 and Exendin(9-39) 600 (drug)
GLP-1 and Exendin(9-39) 900 (drug)
GLP-1 and Exendin(9-39) 1200 (drug)

Where the study takes place — 1 listed sites

Ludwig Maximilians University, Clinical Research Unit
Munich, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Comparison Between Patients With or Without Diabetes Recovery After Bariatric Surgery

ClinicalTrials.gov · NCT00834938 · Registry updated: 2011-08-11

Condition / research focus: Diabetes; Bariatric Surgery; Obesity
Sponsor: University of Campinas, Brazil
Countries with listed sites: Brazil
Registry dates and results: Start: 2007-07. Completion: 2010-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

No intervention (other)

Where the study takes place — 1 listed sites

LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP)
Campinas, São Paulo, Brazil
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Peanuts Second Meal Glycemic Response

ClinicalTrials.gov · NCT01413126 · Registry updated: 2011-08-10

Condition / research focus: Type 2 Diabetes Mellitus
Sponsor: Federal University of Vicosa
Countries with listed sites: Brazil
Registry dates and results: Start: 2009-10. Completion: 2011-02 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Whole peanuts without skins, Peanut butter, or no peanuts (control) (dietary_supplement)

Where the study takes place — 1 listed sites

Federal University of Viçosa
Viçosa, Minas Gerais, Brazil
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Glucose Metabolism in the Immediate and Short Term Follow up After Bariatric Surgery

ClinicalTrials.gov · NCT00488423 · Registry updated: 2011-06-22

Condition / research focus: Diabetes; Gastric Bypass
Sponsor: The Cleveland Clinic
Countries with listed sites: United States
Registry dates and results: Start: 2006-11. Completion: 2008-11 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Mixed Meal Tolerance test, Hyperglycemic clamp (procedure) — also listed as: MMTT

Where the study takes place — 1 listed sites

Cleveland Clinic
Cleveland, Ohio, United States
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Insulinotropic Effect of GIP and GLP-1 Before and After Reduced Glucose Tolerance

ClinicalTrials.gov · NCT01173978 · Registry updated: 2011-06-21

Condition / research focus: Insulin Resistance; Deteriorated Glucose Homeostasis; Inactivity
Sponsor: Glostrup University Hospital, Copenhagen
Countries with listed sites: Denmark
Registry dates and results: Start: 2010-04. Completion: 2010-07 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Steroid hormone (behavioral) — also listed as: Prednisolone
No intervention (other)

Where the study takes place — 1 listed sites

Department of Clinical Physiology
Glostrup Municipality, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2UnknownINTERVENTIONAL

The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus

ClinicalTrials.gov · NCT01342042 · Registry updated: 2011-04-26

Condition / research focus: Type 2 Diabetes
Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Countries with listed sites: China
Registry dates and results: Start: 2011-03. Completion: 2011-12 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

rExenatide-4 (biological)

Where the study takes place — 1 listed sites

Peking University First Hospital
Beijing, Beijing Municipality, China
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Treatment With Sitagliptin for Reactive Hypoglycemia Secondary to Dysinsulinism

ClinicalTrials.gov · NCT00847080 · Registry updated: 2011-04-26

Condition / research focus: Reactive Hypoglycemia
Sponsor: Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Countries with listed sites: Mexico
Registry dates and results: Start: 2008-12. Completion: 2011-03 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Sitagliptin phosphate (drug) — also listed as: Januvia
Placebo (drug)

Where the study takes place — 1 listed sites

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Mexico City, Mexico City, Mexico
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Gut Hormones After Roux-en-Y Gastric Bypass (RYGBP) Plus Gastric Fundus Resection

ClinicalTrials.gov · NCT01341028 · Registry updated: 2011-04-25

Condition / research focus: Morbid Obesity
Sponsor: University of Patras
Countries with listed sites: Greece
Registry dates and results: Start: 2007-05. Completion: 2010-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Roux-en-Y gastric bypass (LRYGBP) (procedure) — also listed as: LRYGBP
LRYGBP+gastric fundus resection (procedure)

Where the study takes place — 1 listed sites

University Hospital of Patras
Rio, Achaia, Greece
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Effect of GLP-1 on Glucose Metabolism in CNS Assessed by PET

ClinicalTrials.gov · NCT01185119 · Registry updated: 2011-03-22

Condition / research focus: Healthy
Sponsor: University of Aarhus
Countries with listed sites: Denmark
Registry dates and results: Start: 2010-06. Completion: 2011-03 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

native glp-1 (7-36) (drug) — also listed as: glucagon like peptide-1 (7-36)

Where the study takes place — 1 listed sites

Aarhus University, Institute of Pharmacology
Aarhus C, Aarhus, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 4CompletedINTERVENTIONAL

Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus

ClinicalTrials.gov · NCT01208012 · Registry updated: 2011-03-15

Condition / research focus: Diabetes Mellitus, Type 2
Sponsor: ikfe-CRO GmbH
Countries with listed sites: Germany
Registry dates and results: Start: 2010-04. Completion: 2010-11 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Victoza® (drug) — also listed as: Victoza®, Liraglutide

Where the study takes place — 1 listed sites

IKFE Institute for Clinical Research and Development
Mainz, Germany
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

Sweet Taste Receptors and the Secretion of Glucagon-like Peptide-1 and Peptide YY

ClinicalTrials.gov · NCT01088841 · Registry updated: 2011-02-23

Condition / research focus: Appetite and General Nutritional Disorders; Hormone Replacement
Sponsor: University Hospital, Basel, Switzerland
Countries with listed sites: Switzerland
Registry dates and results: Start: 2009-04. Completion: 2010-03 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

lactisole (dietary_supplement) — also listed as: Glucose, water

Where the study takes place — 1 listed sites

University Hospital Basel, Clinical Research Center
Basel, Switzerland
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Characterization of the Incretinpathy in Type 2 Diabetes Initiated After Sixty Years Old

ClinicalTrials.gov · NCT00843232 · Registry updated: 2011-02-04

Condition / research focus: Diabetes Mellitus, Type 2; Insulin Resistance
Sponsor: University of Campinas, Brazil
Countries with listed sites: Brazil
Registry dates and results: Start: 2009-07. Completion: 2010-09 (may be estimated). No results posted in this registry response.

Products and interventions (0)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Where the study takes place — 1 listed sites

LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP)
Campinas, São Paulo, Brazil
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Not applicableCompletedINTERVENTIONAL

Effect of GLP-1 and GIP on Insulin Secretion in Type-1 Diabetes Mellitus

ClinicalTrials.gov · NCT00603031 · Registry updated: 2011-01-21

Condition / research focus: Type-1 Diabetes Mellitus
Sponsor: Hvidovre University Hospital
Countries with listed sites: Denmark
Registry dates and results: Start: 2008-01. Completion: 2008-06 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

glucagon like peptide -1 (other)
NaCl (other)
glucose dependent insulinotropic polypeptide (other)

Where the study takes place — 1 listed sites

Dept. of Endocrinology, Hvidovre Hospital
Copenhagen, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 2 / Phase 3CompletedINTERVENTIONAL

Effect of GLP-1 on Insulin-dose, Risk of Hypoglycemia and Gastric Emptying Rate in Patients With Type 1 Diabetes

ClinicalTrials.gov · NCT00993720 · Registry updated: 2011-01-21

Condition / research focus: Diabetes Mellitus
Sponsor: Hvidovre University Hospital
Countries with listed sites: Denmark
Registry dates and results: Start: 2009-10. Completion: 2010-10 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Liraglutide (drug)
Liraglutide (drug)
continuous insulin therapy (other)

Where the study takes place — 1 listed sites

Hvidovre University Hospital
Hvidovre, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase not reported / not applicableCompletedOBSERVATIONAL

Study of Postprandial Incretin Response in Women With Gestational Diabetes

ClinicalTrials.gov · NCT01274052 · Registry updated: 2011-01-11

Condition / research focus: Gestational Diabetes Mellitus
Sponsor: University Hospital, Gentofte, Copenhagen
Countries with listed sites: Denmark
Registry dates and results: Start: 2007-03. Completion: 2008-07 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Meal test (other)

Where the study takes place — 1 listed sites

Department of Internal Medicine, Glostrup Hospital
Glostrup Municipality, Denmark
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 3UnknownINTERVENTIONAL

Effect of Additional Treatment With EXenatide in Patients With an Acute Myocardial Infarction (the EXAMI Trial)

ClinicalTrials.gov · NCT01254123 · Registry updated: 2010-12-06

Condition / research focus: Patients With a First Acute Myocardial Infarction to be Treated With Primary Percutaneous Coronary Intervention (PCI).
Sponsor: Amsterdam UMC, location VUmc
Countries with listed sites: Netherlands
Registry dates and results: Start: 2009-11. Completion: Not reported (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Exenatide infusion (drug)
Placebo infusion. (drug)

Where the study takes place — 1 listed sites

VU Medical Center
Amsterdam, Netherlands
Site recruitment: Recruiting

Original record, eligibility, contacts and results →

Phase 3CompletedINTERVENTIONAL

Exploratory Study of Additional Use of Scopolamine Butylbromide, Glucagon or NPO-11 Following Single Dose of NPO-11 in Healthy Adult Men

ClinicalTrials.gov · NCT00740324 · Registry updated: 2010-11-09

Condition / research focus: Healthy
Sponsor: Nihon Pharmaceutical Co., Ltd
Countries with listed sites: Japan
Registry dates and results: Start: 2008-08. Completion: 2009-07 (may be estimated). No results posted in this registry response.

Products and interventions (3)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

NPO-11 (drug)
NPO-11 (drug)
NPO-11 (drug)

Where the study takes place — 1 listed sites

Facility not reported
Tokyo, Japan
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1 / Phase 2TerminatedINTERVENTIONAL

Treatment of Type 2 Diabetes Mellitus by Duodenal Exclusion Associated With Omentectomy: Clinical and Hormonal Study

ClinicalTrials.gov · NCT00566215 · Registry updated: 2010-07-23

Condition / research focus: Diabetes Mellitus, Type 2; Insulin Resistance; Obesity
Sponsor: University of Campinas, Brazil
Countries with listed sites: Brazil
Registry dates and results: Start: 2007-07. Completion: 2009-06 (may be estimated). No results posted in this registry response.

Products and interventions (2)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Duodenal exclusion plus omentectomy (procedure) — also listed as: Duodenojejunal exclusion plus omentectomy, Duodenal-jejunal bypass plus omentectomy
Duodenal exclusion without omentectomy (procedure) — also listed as: Duodenojejunal exclusion, Duodenal-jejunal bypass

Where the study takes place — 1 listed sites

LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP)
Campinas, São Paulo, Brazil
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1 / Phase 2CompletedINTERVENTIONAL

Surgical Treatment of Non-obese Type 2 Diabetic Patients With Duodenal Exclusion

ClinicalTrials.gov · NCT00566358 · Registry updated: 2010-07-21

Condition / research focus: Diabetes Mellitus, Type 2
Sponsor: University of Campinas, Brazil
Countries with listed sites: Brazil
Registry dates and results: Start: 2006-01. Completion: 2009-06 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Duodenal exclusion surgery (procedure) — also listed as: Duodeno-jejunal exclusion, Duodenal-jejunal bypass

Where the study takes place — 1 listed sites

LIMED (Laboratory of Investigation of Metabolism and Diabetes)/GASTROCENTRO/Univeristy of Campinas (UNICAMP)
Campinas, São Paulo, Brazil
Site recruitment: Not reported

Original record, eligibility, contacts and results →

Phase 1CompletedINTERVENTIONAL

GIP and GLP-1 on Gastric Emptying, Appetite and Insulin-glucose

ClinicalTrials.gov · NCT01079624 · Registry updated: 2010-03-03

Condition / research focus: Physiology; Gastroenterology; Endocrinology
Sponsor: Uppsala University
Countries with listed sites: Sweden
Registry dates and results: Start: 2006-08. Completion: 2009-11 (may be estimated). No results posted in this registry response.

Products and interventions (1)

Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.

Glucose-insulinotropic peptide, Glucagon-like peptide-1 (other) — also listed as: GIP, GLP-1, Saline

Where the study takes place — 1 listed sites

Karolinska University Hospital
Stockholm, Stockholm County, Sweden
Site recruitment: Not reported

Original record, eligibility, contacts and results →